SBC Medical Group (NASDAQ:SBC) versus Nutex Health (NASDAQ:NUTX) Head-To-Head Review

SBC Medical Group (NASDAQ:SBC) and Nutex Health (NASDAQ:NUTX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Earnings & Valuation

This table compares SBC Medical Group and Nutex Health”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$173.61 million	2.58	$50.99 million	$0.49	8.90
Nutex Health	$875.26 million	0.86	$70.79 million	$8.98	12.01

Nutex Health has higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

SBC Medical Group has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.1, suggesting that its stock price is 90% less volatile than the S&P 500.

Profitability

This table compares SBC Medical Group and Nutex Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	29.37%	20.76%	15.67%
Nutex Health	7.34%	17.67%	7.37%

Institutional & Insider Ownership

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 5.3% of Nutex Health shares are held by institutional investors. 89.5% of SBC Medical Group shares are held by insiders. Comparatively, 44.7% of Nutex Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for SBC Medical Group and Nutex Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1	0	2	0	2.33
Nutex Health	0	1	2	0	2.67

SBC Medical Group currently has a consensus target price of $8.50, suggesting a potential upside of 94.95%. Nutex Health has a consensus target price of $252.50, suggesting a potential upside of 134.14%. Given Nutex Health’s stronger consensus rating and higher possible upside, analysts plainly believe Nutex Health is more favorable than SBC Medical Group.

Summary

SBC Medical Group beats Nutex Health on 7 of the 13 factors compared between the two stocks.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.